Description
Emd is currently under investigation and has not been approved for use in colorectal cancer. Its clinical efficacy and safety profile are still being evaluated in ongoing clinical trials.
Mechanism of Action
Emd is an investigational drug and its mechanism of action has not been fully elucidated or approved by the FDA for clinical use in colorectal cancer.
Side Effects
Not available; side effects are still under investigation and have not been fully documented.
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT01008475
med_phase_prefix1
Archived
EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer
Belgium, Bulgaria, Cyprus, Czechia, Germany, Greece, Hungary, Israel, Poland, Ru